Sign In

Matthew Taylor

Bioengineering researcher studying the fundamental interface of biology and materials.

Matthew Taylor is a Biomaterials researcher with a strong focus on polymer-based drug delivery, including the development of antibacterial, antithrombotic, anti-adsorptive, and cell scaffolding surfaces. His expertise lies in studying bacterial and mammalian cell-surface interactions, particularly in biofilm and clot mitigation, growth behavior, and polymer-based drug/vaccine delivery systems.

He is currently involved in developing lipid nanoparticle delivery systems for mRNA-based therapeutics at Moderna. Matthew Taylor has a Master of Science (M.S.) in Bioengineering from the University of Colorado Denver and a B.S. in Material Science from the Colorado School of Mines.

His professional experience includes roles as a Senior Research Associate at Moderna Therapeutics, Technical Associate at Massachusetts Institute of Technology, Associate Scientist at Semprus BioSciences (now Teleflex Int.), and Research and Design Engineering Intern at Covidien Ltd. He has also contributed to notable publications in the field of biomaterials and drug delivery.

Matthew Taylor
Add to my network

Location

Cambridge, Massachusetts